Clinically significant cardiovascular disease, history of myocardial infarction within the last  months, or evidence of QTc interval prolongation at screening
Currently active clinically significant cardiovascular disease or history of myocardial infarction within  months of first dose
Currently active, clinically significant cardiovascular disease or a history of myocardial infarction within  months prior to inclusion
Currently active, clinically significant cardiovascular disease such as uncontrolled arrhythmia, congestive heart failure, any Class  or  cardiac disease within  months of screening
Currently active, clinically significant cardiovascular disease.
Currently active, clinically significant cardiovascular disease
Currently active, clinically significant cardiovascular disease
Currently active, clinically significant cardiovascular disease or myocardial infarction within  months of screening
Currently active clinically significant cardiovascular disease or history of myocardial infarction within  months of first dose
